ProKidney (PROK) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
ProKidney Corp. has moved to motivate and retain key staff by approving a new Supplemental Equity Award for certain employees, including the Chief Legal Officer Todd Girolamo. This award, part of the 2022 Incentive Equity Plan, grants options for employees to buy shares at market value, with a vesting period that begins on March 1, 2025, for half of the shares, followed by monthly installments over the next year.
For further insights into PROK stock, check out TipRanks’ Stock Analysis page.
